Addition of long-acting beta-agonists to inhaled corticosteroids for chronic asthma in children
21 results
1 - 21
Addition of long-acting beta 2 -agonists to inhaled corticosteroids for chronic asthma in children: Cochrane systematic review- Long‐acting beta2‐agonists as an inhaled corticosteroid‐sparing agent for chronic asthma in adults and children Edited (no change to conclusions)
- Regular treatment with long acting beta agonists versus daily regular treatment with short acting beta agonists in adults and children with stable asthma Edited (no change to conclusions)
- Addition to inhaled corticosteroids of long-acting beta 2 -agonists versus anti-leukotrienes for chronic asthma: Cochrane systematic review
- Long-acting beta2-agonists for chronic asthma in adults and children where background therapy contains varied or no inhaled corticosteroid: Cochrane systematic review
- Combination fluticasone and salmeterol versus fixed dose combination budesonide and formoterol for chronic asthma in adults and children New search for studies and content updated (no change to conclusions)
- Regular treatment with formoterol and an inhaled corticosteroid versus regular treatment with salmeterol and an inhaled corticosteroid for chronic asthma: serious adverse events Edited (no change to conclusions)
- Stopping long‐acting beta2‐agonists (LABA) for children with asthma well controlled on LABA and inhaled corticosteroids Edited (no change to conclusions)
- Inhaled steroids with and without regular formoterol for asthma: serious adverse events Edited (no change to conclusions)
- Combination formoterol and budesonide as maintenance and reliever therapy versus combination inhaler maintenance for chronic asthma in adults and children Edited (no change to conclusions)
- Patient‐ and parent‐initiated oral steroids for asthma exacerbations New
- Inhaled steroids with and without regular salmeterol for asthma: serious adverse events New search for studies and content updated (conclusions changed)